CANF
Can-fite Biopharma·AMEX
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
2.57 / 10Overall Score
UnderperformInvestment Rating
2.57 / 10Overall Score
UnderperformInvestment Rating
Should I Buy CANF Now?
- Based on a composite score of 2.57/10, we rate CANF as a Underperform. Our analysis breaks down into 1.69/10 for Fundamentals, 1.03/10 for Technicals, and 3.79/10 for Sentiment, indicating the stock is likely to Face downward pressure.
What is the current technical signals for CANF?
Is CANF fundamentally strong?
What is the market sentiment for CANF?
Should I Buy CANF Now?
- Based on a composite score of 2.57/10, we rate CANF as a Underperform. Our analysis breaks down into 1.69/10 for Fundamentals, 1.03/10 for Technicals, and 3.79/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Is CANF fundamentally strong?
What is the current technical signals for CANF?
What is the market sentiment for CANF?
